H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target
Legend Biotech Corporation (NASDAQ:LEGN) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On July 2, analyst Mitchell Kapoor from H.C.
Posts Tagged ‘NASDAQ:LEGN’
13 Best Pharma Stocks to Buy According to Wall Street Analysts
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
Legend Biotech Corporation (NASDAQ:LEGN) Q1 2025 Earnings Call Transcript
Legend Biotech Corporation (NASDAQ:LEGN) Q1 2025 Earnings Call Transcript May 13, 2025Legend Biotech Corporation beats earnings expectations.
20 Takeover Rumors Hedge Funds Are Buying
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2024 Earnings Call Transcript
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2024 Earnings Call Transcript March 11, 2025Legend Biotech Corporation beats earnings expectations.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and...
Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Mid-Cap Growth Stocks to Buy According to Analysts
Investing in mid-cap growth stocks has long been a favoured strategy for investors looking to strike a balance between the stability of large-cap companies and the high-growth...
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
12 Stocks That Will Double in 2025
A lot is happening in the market, especially within the growth sectors.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
10 Best Up and Coming Stocks To Buy According to Analysts
Donald Trump's victory in the recent presidential election is expected to encourage companies that have been hesitant to pursue IPOs in 2025, capitalizing on the positive market...
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
12 NASDAQ Stocks with Biggest Upside Potential According to Analysts
Potomac Wealth Advisors president Mark Avallone joined CNBC's 'The Exchange' on November 16 to discuss where he sees investing opportunities following Trump's election.
Legend Biotech Corporation (NASDAQ:LEGN) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2024 Financial Results.
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
Here’s Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” second-quarter 2024 investor letter.
10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
Ray Dalio’s Top 10 Growth Stock Picks with 30+% Revenue Growth
Valuing a stock comes in several shapes and flavors. The most common of these is the price to earnings ratio.
Does Legend Biotech (LEGN) Have a Long Runway for Growth?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first-quarter investor letter.
Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech First Quarter 2024 Financial Results Conference Call.
11 Oversold MidCap Stocks To Buy Now
In this piece, we will take a look at the 11 oversold midcap stocks to buy now.
Should You Continue to Hold Legend Biotech Corporation (LEGN)?
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript
Operator: Good day, and welcome to Legend Biotech Reports Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode.
Should You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
13 High Growth Healthcare Stocks to Buy
In this article, we will take a look at 13 high growth healthcare stocks to buy.
5 Most Promising Healthcare Stocks According to Analysts
In this article, we discuss the 5 most promising healthcare stocks according to analysts.
Legend Biotech Corporation (NASDAQ:LEGN) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2023 Financial Results Conference Call.
Should You Expect Strong Financial Growth from Legend Biotech Corporation (LEGN)?
Baron Funds, an investment management company, released its “Baron Opportunity Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Should You Hold Legend Biotech Corporation (LEGN)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Legend Biotech Corporation (LEGN)’s Stock Witnessed a 43% Increase in Q2
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” second-quarter investor letter.
Legend Biotech Corporation (NASDAQ:LEGN) Q2 2023 Earnings Call Transcript
Operator: Good morning and thank you for standing by. Welcome to the Legend Biotech Reports Second Quarter 2023 Financial Results.
What Makes Legend Biotech Corporation (LEGN) a Unique and Exciting Investment Opportunity?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
12 Most Promising Healthcare Stocks According to Analysts
In this article, we will take a look at the 12 most promising healthcare stocks according to analysts.
Should You Retain Your Holdings in Legend Biotech Corporation (LEGN)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small/Mid Cap Growth Strategy” fourth-quarter investor letter.
10 Most Promising Biotech Stocks According to Analysts
In this article, we discuss 10 most promising biotech stocks according to analysts.
Is Legend Biotech Corporation (LEGN) A Good Investment?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter.
Meridian Funds’ Largest Contributor: Legend Biotech Corporation (LEGN)
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.
5 Biotech Stocks To Buy According To Chinese Billionaire Lei Zhang
In this article, we discuss 5 biotech stocks to buy according to Chinese billionaire Lei Zhang.
Top 5 Stock Picks of Chinese Billionaire Lei Zhang
In this article, we discuss the top 5 stock picks of the Chinese billionaire Lei Zhang.
Hedge Funds Are Coming Back To Legend Biotech Corporation (LEGN)
In this article we will analyze whether Legend Biotech Corporation (NASDAQ:LEGN) is a good investment right now by following the lead of some of the best investors in the world...
Is LEGN A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether Legend Biotech Corporation (NASDAQ:LEGN) is a good investment right now.
